Business Description
Sea Mild Biotechnology Co Ltd
ISIN : TW0007516B19
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.03 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 2.55 | |||||
Interest Coverage | 5.01 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.76 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.3 | |||||
3-Year Book Growth Rate | -20.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.28 | |||||
9-Day RSI | 51.02 | |||||
14-Day RSI | 48.57 | |||||
6-1 Month Momentum % | 10.01 | |||||
12-1 Month Momentum % | -30.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.33 | |||||
Quick Ratio | 1.07 | |||||
Cash Ratio | 0.5 | |||||
Days Inventory | 41.71 | |||||
Days Sales Outstanding | 73.88 | |||||
Days Payable | 77.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -9.15 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.93 | |||||
Operating Margin % | 1.88 | |||||
Net Margin % | 2.41 | |||||
FCF Margin % | 3.44 | |||||
ROE % | 9.2 | |||||
ROA % | 3.53 | |||||
ROIC % | 6.39 | |||||
ROC (Joel Greenblatt) % | 18.18 | |||||
ROCE % | 9.21 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.65 | |||||
PE Ratio without NRI | 30.65 | |||||
Price-to-Owner-Earnings | 71.38 | |||||
PS Ratio | 0.74 | |||||
PB Ratio | 2.69 | |||||
Price-to-Tangible-Book | 2.68 | |||||
Price-to-Free-Cash-Flow | 21.42 | |||||
Price-to-Operating-Cash-Flow | 21.42 | |||||
EV-to-EBIT | 26.46 | |||||
EV-to-EBITDA | 8.7 | |||||
EV-to-Revenue | 0.73 | |||||
EV-to-FCF | 21.36 | |||||
Price-to-Graham-Number | 1.91 | |||||
Price-to-Net-Current-Asset-Value | 6.13 | |||||
Earnings Yield (Greenblatt) % | 3.78 | |||||
FCF Yield % | 4.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sea Mild Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 257.018 | ||
EPS (TTM) (NT$) | 0.32 | ||
Beta | 0.98 | ||
Volatility % | 38.31 | ||
14-Day RSI | 48.57 | ||
14-Day ATR (NT$) | 0.434184 | ||
20-Day SMA (NT$) | 9.7705 | ||
12-1 Month Momentum % | -30.07 | ||
52-Week Range (NT$) | 8.85 - 14.2 | ||
Shares Outstanding (Mil) | 19.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sea Mild Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sea Mild Biotechnology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Sea Mild Biotechnology Co Ltd Frequently Asked Questions
What is Sea Mild Biotechnology Co Ltd(ROCO:7516)'s stock price today?
When is next earnings date of Sea Mild Biotechnology Co Ltd(ROCO:7516)?
Does Sea Mild Biotechnology Co Ltd(ROCO:7516) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |